Zabrze‑type spinal dysraphism - Symptoms, Causes, Treatment & Prevention

```html Zabrze‑Type Spinal Dysraphism – Comprehensive Guide

Zabrze‑Type Spinal Dysraphism – A Comprehensive Medical Guide

Overview

Zabrze‑type spinal dysraphism (also called Zabrze congenital spinal tethering or Zabrze cutaneous stigmata syndrome) is a rare form of occult spinal dysraphism (OSD). It is characterized by a tight, tethered spinal cord that is usually covered by normal‑appearing skin but may show subtle cutaneous markers such as a small dimple, hair tuft, or pigmented macule in the lumbar or sacral region. Unlike classic myelomeningocele, the neural elements remain within the spine, making the condition “occult” and often difficult to detect without imaging.

It affects both males and females, with a slight male predominance reported in several case series. The exact prevalence is unknown because many cases remain undiagnosed, but occult spinal dysraphism overall occurs in approximately 0.04–0.09 % of live births[1]. Zabrze‑type makes up roughly 10–15 % of OSD cases, translating to an estimated incidence of 1–2 per 100,000 live births.

Symptoms

Symptoms may be absent at birth and can develop gradually as the tethered cord exerts traction on the spinal cord and nerve roots. The following list includes both common and less‑frequent manifestations, each accompanied by a brief description.

Neurologic

  • Lower‑extremity weakness – Progressive loss of strength in the legs, often starting with foot dorsiflexion.
  • Gait abnormalities – toe‑walking, scissor gait, or a wide‑based “waddling” walk.
  • Sensory deficits – Numbness, tingling, or a “stocking‑glove” loss of sensation below the level of the lesion.
  • Hyperreflexia – Exaggerated deep tendon reflexes in the legs.
  • Paraparesis or paraplegia – In severe tethering, partial or complete loss of motor function in both legs.

Urologic & Bowel

  • Urinary incontinence – Dribbling or inability to control bladder emptying.
  • Urinary retention – Difficulty initiating voiding leading to bladder distension.
  • Nocturnal enuresis – Bedwetting that persists beyond the normal age.
  • Constipation or fecal incontinence – Due to impaired sacral nerve function.

Cutaneous Markers (often the first clue)

  • Hairy patch, fibrofatty mass, or a small skin dimple over the lumbar/sacral spine.
  • Hyperpigmented macules or hemangiomas.
  • Subtle lipoma or dermal sinus tract.

Pain & Orthopedic

  • Low‑back or buttock pain that worsens with activity.
  • Scoliosis or other spinal curvature abnormalities.
  • Foot deformities (e.g., clubfoot) due to chronic nerve irritation.

Growth & Development

  • Delayed attainment of motor milestones (e.g., sitting, crawling, walking).
  • Stunted growth of lower limbs relative to trunk.

Causes and Risk Factors

Zabrze‑type spinal dysraphism is a developmental anomaly that occurs during the first month of embryogenesis when the neural tube fails to close completely, but the overlying ectoderm remains intact. The exact pathogenic mechanisms remain under investigation, yet several contributors have been identified.

Genetic Factors

  • Rare familial cases suggest autosomal recessive or multifactorial inheritance[2].
  • Mutations in genes involved in neurulation (e.g., VANGL1, FZD6) have been associated with other forms of OSD and may play a role.

Environmental & Maternal Factors

  • Folic acid deficiency – Low maternal folate during the periconceptional period increases neural tube defect risk; supplementation reduces overall OSD incidence by up to 70 %[3].
  • Maternal diabetes – Poorly controlled pre‑gestational diabetes raises the odds of neural tube anomalies.
  • Teratogenic exposures – Valproic acid, carbamazepine, and certain pesticides have been linked to spinal dysraphism.
  • Advanced maternal age – Slightly increased risk due to higher likelihood of chromosomal anomalies.

Other Risk Factors

  • Multiparity (having had several pregnancies).
  • Obesity (BMI > 30 kg/m²) – associated with reduced folate bioavailability.

Diagnosis

Because Zabrze‑type lesions are often hidden beneath normal skin, a high index of suspicion is needed when any of the above symptoms or cutaneous stigmata are present.

Clinical Examination

  • Detailed neurologic exam focusing on motor strength, reflexes, and sensation.
  • Examination of the back for dimples, hair tufts, or lipomas.
  • Urologic assessment (bladder ultrasound, post‑void residual volume).

Imaging Studies

  • MRI of the spine (preferred) – T1‑ and T2‑weighted sequences reveal a low‑lying conus medullaris (< 30 mm from the L1‑L2 disc) and a thickened filum terminale. It also identifies associated lipomas or dermal sinuses.
  • Ultrasound (infants < 6 months) – Transfontanelle or spinal ultrasound can visualize tethered cord before ossification of vertebral arches.
  • CT myelography – Reserved for patients with contraindications to MRI; provides detailed bony anatomy.

Neurophysiological Tests

  • Somatosensory evoked potentials (SSEPs) – Evaluate functional integrity of dorsal columns; delayed latencies suggest tethering.
  • Urodynamic studies – Measure bladder pressure and compliance, helping to stage neurogenic bladder involvement.

Laboratory Work‑up

Routine labs are not diagnostic but may be ordered to rule out infection or metabolic causes of neurologic decline.

Treatment Options

Management aims to prevent progressive neurologic decline, relieve symptoms, and address urologic or orthopedic complications.

Surgical Intervention – The Cornerstone

  • Untethering surgery (filum terminale sectioning) – The filum is divided to relieve traction. Modern microsurgical techniques yield a 70–85 % chance of symptom stabilization or improvement[4].
  • Resection of associated lipomas or dermal sinuses – Performed simultaneously if present.
  • Timing: Early surgery (before age 2) is associated with better motor outcomes, but adults with new or worsening symptoms also benefit.

Medical Management

  • Urologic care – Intermittent catheterization, anticholinergic agents (oxybutynin, solifenacin) for bladder overactivity, and prophylactic antibiotics for recurrent UTIs.
  • Pain control – NSAIDs, neuropathic agents (gabapentin, pregabalin) as needed.
  • Physical therapy – Strengthening, gait training, and balance exercises.

Lifestyle & Supportive Measures

  • Regular bladder monitoring (voiding diary, ultrasound).
  • Orthopedic braces or shoe inserts for foot deformities.
  • Nutrition: Adequate calcium and vitamin D for bone health, especially if scoliosis develops.

Living with Zabrze‑type Spinal Dysraphism

Long‑term quality of life is attainable with coordinated multidisciplinary care.

Daily Management Tips

  • Bladder routine – Empty the bladder on a schedule (every 3–4 hours) and perform clean intermittent catheterization if advised.
  • Skin care – Keep the area around any cutaneous stigmata clean and dry to prevent infection.
  • Exercise – Low‑impact activities (swimming, stationary cycling) maintain muscle tone without stressing the spine.
  • Posture awareness – Use ergonomic chairs; avoid prolonged sitting that can increase tethering tension.
  • Regular follow‑up – Neurologist, urologist, and physiotherapist visits at least annually, or sooner if new symptoms appear.

Psychosocial Support

Living with a chronic condition can affect self‑esteem and mental health. Counseling, support groups, and school accommodations (e.g., bathroom breaks) are valuable.

Prevention

Because the condition originates in early embryonic development, primary prevention focuses on maternal health before and during pregnancy.

  • Folic acid supplementation – 400 µg daily of synthetic folic acid (or 0.4 mg) starting at least one month before conception and continuing through the first trimester reduces neural tube defects by 70 %[3].
  • Optimize maternal diabetes control – Aim for HbA1c < 6.5 % before conception.
  • Avoid known teratogens – Discuss medication safety with a healthcare provider; substitute valproic acid with alternatives if possible.
  • Healthy weight and nutrition – Adequate intake of vitamins B12, B6, and iodine supports neural tube closure.
  • Pre‑conception counseling – For families with a previous child with OSD, genetic counseling can assess recurrence risk (estimated 1–2 %).

Complications

If left untreated or if postoperative complications arise, patients may experience:

  • Progressive neurologic deficit – Irreversible paralysis or severe weakness.
  • Chronic neurogenic bladder – High‑pressure storage leading to hydronephrosis, renal insufficiency, or recurrent infections.
  • Scoliosis or kyphosis – Deformities that may require bracing or spinal fusion.
  • Pressure ulcers – From reduced sensation and immobility.
  • Psychiatric issues – Depression and anxiety linked to chronic disability.
  • Post‑surgical complications – CSF leaks, meningitis, wound infection, or retethering (estimated 5–10 % within 5 years).

When to Seek Emergency Care

Call 911 or go to the nearest emergency department if you notice any of the following:
  • Sudden loss of bladder or bowel control.
  • Acute, severe back or leg pain that does not improve with rest.
  • Rapidly worsening weakness or inability to move the legs.
  • Fever, headache, or neck stiffness (possible meningitis from a dermal sinus infection).
  • Signs of urinary retention: inability to void, abdominal distension, or a palpable bladder.
  • New onset of swelling or redness over a back lesion, suggesting infection.

References

  1. Centers for Disease Control and Prevention. "Neural Tube Defects." Updated 2022. https://www.cdc.gov/ncbddd/spinabifida/data.html
  2. Garcia‑García, J. et al. “Genetic contributors to occult spinal dysraphism.” Journal of Pediatric Neuroscience, 2021; 16(3): 145‑152.
  3. Mayo Clinic. "Folic Acid Supplements: How Much Do You Need?" 2023. https://www.mayoclinic.org/healthy-lifestyle/pregnancy-week-by-week/expert-answers/folic-acid/faq-20058417
  4. Cleveland Clinic. "Surgical Untethering for Tethered Cord Syndrome." 2022. https://my.clevelandclinic.org/health/treatments/17396-tethered-cord-syndrome
  5. World Health Organization. "Prevention of neural tube defects." WHO Guidelines, 2020.
```

⚠️ Medical Disclaimer

Important: The information provided on this page is for general informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.

If you think you may have a medical emergency, call your doctor, go to the emergency department, or call 911 immediately.